NCT05257993: Study to Assess the Safety, Tolerability of JPI-547 in Combination With Modified FOLFIRINOX or Gemcitabine-nab-paclitaxel in Patients With Locally Advanced and Metastatic Pancreatic Cancer |
|
|
| Not yet recruiting | 1 | 24 | NA | JPI-547, modified FOLFIRINOX, Gemcitabine-nab-paclitaxel | Onconic Therapeutics Inc. | Pancreatic Ductal Adenocarcinoma | 08/23 | 08/23 | | |